Literature DB >> 11712863

Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis.

M Matsushita1, H Miyakawa, A Tanaka, M Hijikata, K Kikuchi, H Fujikawa, J Arai, S Sainokami, K Hino, I Terai, S Mishiro, M E Gershwin.   

Abstract

Although the immunopathogenesis of primary biliary cirrhosis (PBC) remains unknown, familial clustering of patients with PBC suggests an important role for genetic factors. In addition, recent data support the thesis that the mucosal immune response against intraluminal pathogens may be involved with the onset of PBC. Mannose-binding lectin (MBL) is a key factor in innate mucosal defenses and has several key single nucleotide polymorphisms (SNPs). To study whether MBL gene SNPs are associated with susceptibility to PBC, we studied 65 patients with PBC and 218 controls by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and sequence specific priming-polymerase chain reaction (SSP-PCR) to examine four polymorphic loci: two (H/L and X/Y) within the promoter region and the other two (P/Q and A/B) within exon-1. We also analyzed serum MBL concentrations. Interestingly, the prevalence of haplotype HYPA, leading to hyper-production of MBL, as well as HYPA/HYPA genotype were significantly increased in PBC compared to controls (0.53 vs. 0.44, P=0.031; 33.9%vs. 17.0%, P=0.003, respectively). Furthermore, individuals homozygous for HYPA had a significantly increased risk for PBC (odds ratio (OR)=2.51, 95% confidence interval (CI)=1.34-4.66). Our results demonstrate that the MBL genotype can be significantly associated with increased risk for PBC, and further, that increased production of MBL plays a critical role in immunopathogenesis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712863     DOI: 10.1006/jaut.2001.0538

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping.

Authors:  Nicolas Vogel; Katrin Schiebel; Andreas Humeny
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

2.  Mannose-binding lectin and pulmonary morbidity in premature infants.

Authors:  Rachel S Agbeko; Mark J Peters
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

3.  Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent.

Authors:  M S Muhlebach; S L MacDonald; B Button; J J Hubbard; M L Turner; R C Boucher; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children.

Authors:  Jia Chen; Zhene Xu; Xi Ou; Mo Wang; Xiqiang Yang; Qiu Li
Journal:  Eur J Pediatr       Date:  2009-01-24       Impact factor: 3.183

5.  Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene.

Authors:  Sharon R Pine; Leah E Mechanic; Stefan Ambs; Elise D Bowman; Stephen J Chanock; Christopher Loffredo; Peter G Shields; Curtis C Harris
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506

Review 6.  Mannose-Binding Lectin: Biologic Characteristics and Role in the Susceptibility to Infections and Ischemia-Reperfusion Related Injury in Critically Ill Neonates.

Authors:  Cinzia Auriti; Giusi Prencipe; Maria Moriondo; Iliana Bersani; Chiara Bertaina; Vito Mondì; Rita Inglese
Journal:  J Immunol Res       Date:  2017-01-26       Impact factor: 4.818

Review 7.  Bench-to-bedside review: Association of genetic variation with sepsis.

Authors:  Ainsley M Sutherland; Keith R Walley
Journal:  Crit Care       Date:  2009-04-29       Impact factor: 9.097

Review 8.  Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both?

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.